Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MDXH

MDxHealth SA

Apr 24 • 11:40AM ET

2.49

Dollar change +0.04
Percentage change 1.55	%

Healthcare • Diagnostics & Research • Belgium • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.65	Insider Own	45.61%	Shs Outstand	27.29M	Perf Week	8.17%
Market Cap	67.90M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.00%	Shs Float	14.84M	Perf Month	-0.08%
Income	-43.10M	PEG	-	EPS next Q	-0.30	Inst Own	19.02%	Short Float	0.11%	Perf Quarter	-35.21%
Sales	70.19M	P/S	0.97	EPS this Y	38.60%	Inst Trans	-	Short Ratio	0.23	Perf Half Y	4.54%
Book/sh	0.66	P/B	3.77	EPS next Y	36.67%	ROA	-	Short Interest	0.02M	Perf Year	-38.87%
Cash/sh	0.82	P/C	3.03	EPS next 5Y	-	ROE	-	52W Range	2.15 - 4.64	Perf YTD	-36.85%
Dividend Est.	-	P/FCF	-	EPS past 5Y	21.68%	ROI	-92.99%	52W High	-46.38%	Beta	0.50
Dividend TTM	-	Quick Ratio	1.81	Sales past 5Y	34.90%	Gross Margin	62.58%	52W Low	15.72%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	1.95	EPS Y/Y TTM	40.40%	Oper. Margin	-38.27%	RSI (14)	45.88	Volatility	6.31% 7.72%
Employees	-	Debt/Eq	5.72	Sales Y/Y TTM	-	Profit Margin	-61.40%	Recom	1.00	Target Price	6.75
Option/Short	No / Yes	LT Debt/Eq	5.43	EPS Q/Q	-	Payout	-	Rel Volume	0.75	Prev Close	2.45
Sales Surprise	4.52%	EPS Surprise	-84.75%	Sales Q/Q	23.15%	Earnings	Mar 06 AMC	Avg Volume	74.83K	Price	2.49
SMA20	-0.09%	SMA50	-15.21%	SMA200	-22.32%	Trades		Volume	31,747	Change	1.55%

Date	Action	Analyst	Rating Change	Price Target Change
May-31-23	Initiated	TD Cowen	Outperform	$7
Jul-18-22	Resumed	Oppenheimer	Outperform	$18

Mar-28-24 01:30PM	These 2 Strong Buy Penny Stocks Could Go Boom, Say Analysts (TipRanks) +5.28%
Mar-12-24 04:00PM	Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering (GlobeNewswire) -8.77%
Mar-07-24 10:42AM	MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call Transcript (Insider Monkey) -17.43%
Mar-06-24 04:00PM	Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-21-24 05:00PM	MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 (GlobeNewswire)
08:45AM	Loading…
Feb-16-24 08:45AM	Mdxhealth Announces Resignation of Board Member (GlobeNewswire)
Jan-08-24 04:00PM	MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance (GlobeNewswire)
Dec-18-23 01:00AM	MDxHealth Announces Completion of Transition to Single Listing on Nasdaq (GlobeNewswire)
Nov-27-23 01:00AM	MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq (GlobeNewswire) -7.36%
Nov-14-23 04:00PM	MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 04:00PM	MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights (GlobeNewswire) +13.48%
Nov-08-23 04:00PM	MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 (GlobeNewswire)
Nov-06-23 01:00AM	MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation (GlobeNewswire)
Oct-25-23 04:00PM	MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 (GlobeNewswire)
Oct-20-23 04:00PM	Mdxhealth's New Share Capital Amount and New Number of Shares (GlobeNewswire)
04:00PM	Loading…
Oct-09-23 04:00PM	MDxHealth Reports Preliminary Q3-2023 Revenues (GlobeNewswire)
Oct-02-23 04:04PM	MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting (GlobeNewswire) -8.57%
Sep-26-23 04:46PM	Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer (GlobeNewswire)
Aug-23-23 04:00PM	MDxHealth Reports Q2 and Half Year 2023 Results (GlobeNewswire)
Aug-10-23 04:00PM	MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 (GlobeNewswire)
Aug-09-23 04:00PM	Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealths Select mdx for Prostate Cancer Test (GlobeNewswire)
Aug-03-23 07:25PM	AMN Healthcare Services (AMN) Beats Q2 Earnings and Revenue Estimates (Zacks) +8.12%
Jun-30-23 04:00PM	MDxHealth Announces Results of its Extraordinary General Shareholders Meeting (GlobeNewswire) +6.56%
Jun-05-23 05:30PM	MDxHealth Announces its Extraordinary General Shareholders Meeting (GlobeNewswire)
May-25-23 04:30PM	MDxHealth Announces Results of its Annual and Extraordinary General Shareholders Meetings (GlobeNewswire) -7.55%
May-23-23 04:00PM	MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference (GlobeNewswire)
May-15-23 04:00PM	MDxHealth Reports Q1-2023 Results (GlobeNewswire)
May-01-23 04:00PM	MDxHealth to Present First Quarter 2023 Financial Results on May 15 (GlobeNewswire)
Apr-25-23 04:00PM	MDxHealth Announces its Ordinary and Extraordinary General Shareholders Meetings (GlobeNewswire)
Apr-19-23 04:00PM	Foundational LCD Covers Select mdx for Prostate Cancer (GlobeNewswire)
04:30PM	Loading…
Apr-07-23 04:30PM	MDxHealth Shareholder Transparency Declaration (GlobeNewswire)
Mar-13-23 02:00AM	MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank (GlobeNewswire) -11.53%
Mar-08-23 05:00PM	MDxHealth Announces Update of Outstanding Shares and Voting Rights (GlobeNewswire)
04:00PM	MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023 (GlobeNewswire)
Mar-06-23 05:34PM	MDxHealth Announces Exercise of Option (GlobeNewswire)
Mar-03-23 04:30PM	MDxHealth Shareholder Transparency Declarations (GlobeNewswire)
Feb-28-23 04:30PM	MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-22-23 04:30PM	MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (GlobeNewswire)
Feb-21-23 04:30PM	MDxHealth Shareholder Transparency Declaration (GlobeNewswire)
Feb-15-23 04:30PM	MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar (GlobeNewswire)
Feb-13-23 04:00PM	MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test (GlobeNewswire)
Feb-03-23 08:00AM	MDxHealth Announces Pricing of Offering of ADSs in the United States (GlobeNewswire) -35.27%
Feb-01-23 04:00PM	MDxHealth Announces Launch of Offering of ADSs in the United States (GlobeNewswire)
Jan-20-23 01:00AM	MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test (GlobeNewswire)
Jan-09-23 04:00PM	MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance (GlobeNewswire)
Dec-19-22 05:00PM	Mdxhealth files U.S. Shelf Registration on Form F-3 (GlobeNewswire)
Nov-29-22 04:06PM	MDxHealth Provides Business Update (GlobeNewswire) -8.37%
Nov-04-22 01:33PM	Exact Sciences expects profitability in 2023, ahead of prior estimate (American City Business Journals) -7.64%
Oct-27-22 04:00PM	MDxHealth Reports Q3-2022 Results (GlobeNewswire)
Aug-25-22 04:00PM	MDxHealth Reports Half Year 2022 Results (GlobeNewswire)
Aug-19-22 04:00PM	Mdxhealth's New Share Capital Amount and New Number of Shares (GlobeNewswire) +6.87%
Aug-09-22 10:09AM	Is a Surprise Coming for MDxHealth (MDXH) This Earnings Season? (Zacks)
Aug-02-22 04:30PM	Edited Transcript of MDXH.BR earnings conference call or presentation 2-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:00PM	Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results (GlobeNewswire)
May-25-22 04:00PM	MDxHealth Announces Results of its Annual and Extraordinary General Shareholders Meetings and Resignation of Director (GlobeNewswire) -5.06%
May-19-22 04:00PM	Palmetto GBAs MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer (GlobeNewswire)
Apr-27-22 04:00PM	MDxHealth Reports Q1-2022 Results (GlobeNewswire)
Apr-25-22 04:00PM	MDxHealth Announces its Ordinary and Extraordinary General Shareholders Meetings (GlobeNewswire)
Mar-30-22 04:30PM	MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference (GlobeNewswire) -6.64%
Mar-02-22 04:00PM	MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022 (GlobeNewswire)
Feb-17-22 04:00PM	MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd (GlobeNewswire)
Feb-09-22 04:00PM	MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Dec-10-21 06:01PM	MDxHealth Shareholder Transparency Declaration (GlobeNewswire) -5.06%
Nov-22-21 05:00PM	MDxHealth Shareholder Transparency Declarations (GlobeNewswire)
Nov-15-21 05:00PM	MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States (GlobeNewswire)
Nov-09-21 03:38PM	DLA Piper advises underwriters in MDxHealth SA's IPO of American depository shares (PR Newswire) -5.31%

MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDXH

MDxHealth SA

Upgrade your FINVIZ experience